CAPR

CAPR R&D to Revenue

0.00%Fiscal year

Period ending:

CAPR FY R&D/Revenue%
CAPR FY R&D/Revenue6206.49%-664.98%
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CAPR r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Capricor Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
224.3715%
144.7611%
855.074%
5,541.5091%
2,725.8662%
511.6081%
722.1424%
403.826%
502.884%
364.3273%
186.8731%
1,032.7224%
523.7852%
305.3137%
0%
0%
0%
5,053.2544%
708.9832%
0%
0%
0%
0%
0%
0%
0%

Compare r&d to revenue

All CAPR financial metrics · CAPR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.